Adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson medication · schizophrenia
1 finding from 1 review
Adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson medication · schizophrenia
QUETIAPINE probably leads to lower adverse effects: 2. Extrapyramidal effects use of antiparkinson… compared with PALIPERIDONE (moderate certainty).
1 finding from 1 review
Adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson medication · schizophrenia
QUETIAPINE probably leads to lower adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson… compared with RISPERIDONE (moderate certainty).
1 finding from 1 review
Adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson medication · schizophrenia
QUETIAPINE may leads to lower adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson… compared with ZIPRASIDONE (low certainty).
1 finding from 1 review
Adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson medication · schizophrenia
QUETIAPINE showed no clear difference in adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson… compared with ARIPIPRAZOLE (low certainty).
1 finding from 1 review
Use of antiparkinsonian medications · people with psychosis
1 finding from 1 review
Moderate‐to‐severe exacerbations (rate) · patients with chronic obstructive pulmonary disease
Long‐acting beta2‐agonists showed no clear difference in severe/moderate exacerbations (hospitalisation or course of… compared with placebo (moderate certainty).
1 finding from 1 review
Global state: 1. Requiring supplementary medication ‐ antipsychotics · patients with acute schizophrenia and similar serious mental illnesses
ZUCLOPENTHIXOL ACETATE showed no clear difference in global state: 1. Requiring supplementary medication ‐ antipsychotics compared with STANDARD DRUG CARE (low certainty).
1 finding from 1 review
Global state: 1. Requiring supplementary medication ‐ antipsychotics · patients with acute schizophrenia and similar serious mental illnesses
1 finding from 1 review
Compliance/satisfaction: medication ‐ not compliant ‐ long‐term · schizophrenia
It is very uncertain whether technology‐mediated psychoeducation + standard care intervention changes compliance/satisfaction: medication ‐ not compliant ‐ long‐term compared with standard care intervention (very low certainty).
1 finding from 1 review
Intervention not reported
Medication adherence/adverse effects · adults with diabetes mellitus and depression
1 finding from 1 review
Intervention not reported
Medication adherence/adverse effects · adults with diabetes mellitus and depression
1 finding from 1 review
Intervention not reported
Percentage of well days during the grass pollen season Well days were those days with a symptom score of less than or equal to 2, and no use of rescue medication Scale from: 0 to 100 · patients with allergic rhinitis1
1 finding from 1 review
Intervention not reported
Percentage of days requiring rescue medication (i.e. as tablets) during the grass pollen season Self recorded each day4 Scale from: 0 to 100 · patients with allergic rhinitis1
1 finding from 1 review
Global state: clinically important change in global state needing additional medication ‐ chlorpromazine · patients with schizophrenia
It is very uncertain whether α‐FLUPENTHIXOL changes global state: clinically important change in global state needing… compared with PLACEBO or β‐FLUPENTHIXOL (very low certainty).
1 finding from 1 review
Compliance: Poor compliance with medication · patients with schizophrenia
It is very uncertain whether ANY FORM OF PSYCHOEDUCATION changes compliance: Not compliant with medication compared with STANDARD CARE (very low certainty).
1 finding from 1 review
Intervention not reported
Concomitant medication (Anxiolytic ‐ Lorazepam) · people with schizophrenia or like psychosis
The intervention may leads to lower concomitant medication (Anxiolytic ‐ Lorazepam) (low certainty).
1 finding from 1 review
Combined symptom‐medication scores Symptom scores · patients with allergic conjunctivitis
1 finding from 1 review
Compliance: Poor compliance with medication · patients with schizophrenia
ANY FAMILY BASED INTERVENTIONS (>5 sessions) may leads to lower compliance: Poor compliance with medication compared with STANDARD CARE (low certainty).
1 finding from 1 review
Adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson medication · patients with schizophrenia
ZOTEPINE showed no clear difference in adverse effects: Extrapyramidal effects ‐ use of antiparkinson… compared with REMOXIPRIDE (low certainty).
1 finding from 1 review